Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 6
1995 3
1996 1
1997 4
1998 2
1999 1
2000 4
2001 3
2004 2
2005 2
2006 2
2007 5
2008 2
2009 2
2010 2
2011 17
2012 10
2013 9
2014 8
2015 12
2016 13
2017 7
2018 11
2019 7
2020 6
2021 7
2022 10
2023 8
2024 7
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

158 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.
Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Julious S, Rajbhandari S, Sharma S, Rayman G, Gouni R, Alam U, Cooper C, Loban A, Sutherland K, Glover R, Waterhouse S, Turton E, Horspool M, Gandhi R, Maguire D, Jude EB, Ahmed SH, Vas P, Hariman C, McDougall C, Devers M, Tsatlidis V, Johnson M, Rice ASC, Bouhassira D, Bennett DL, Selvarajah D; OPTION-DM trial group. Tesfaye S, et al. Among authors: julious s. Lancet. 2022 Aug 27;400(10353):680-690. doi: 10.1016/S0140-6736(22)01472-6. Epub 2022 Aug 22. Lancet. 2022. PMID: 36007534 Free PMC article. Clinical Trial.
CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials.
Junqueira DR, Zorzela L, Golder S, Loke Y, Gagnier JJ, Julious SA, Li T, Mayo-Wilson E, Pham B, Phillips R, Santaguida P, Scherer RW, Gøtzsche PC, Moher D, Ioannidis JPA, Vohra S; CONSORT Harms Group. Junqueira DR, et al. Among authors: julious sa. BMJ. 2023 Apr 24;381:e073725. doi: 10.1136/bmj-2022-073725. BMJ. 2023. PMID: 37094878 Free article. Clinical Trial. No abstract available.
Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.
Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Young T, Rajbhandari S, Sharma S, Rayman G, Gouni R, Alam U, Julious SA, Cooper C, Loban A, Sutherland K, Glover R, Waterhouse S, Turton E, Horspool M, Gandhi R, Maguire D, Jude E, Ahmed SH, Vas P, Hariman C, McDougall C, Devers M, Tsatlidis V, Johnson M, Bouhassira D, Bennett DL, Selvarajah D. Tesfaye S, et al. Among authors: julious sa. Health Technol Assess. 2022 Oct;26(39):1-100. doi: 10.3310/RXUO6757. Health Technol Assess. 2022. PMID: 36259684 Free PMC article. Clinical Trial.
Pilot Studies in clinical research.
Julious SA. Julious SA. Stat Methods Med Res. 2016 Jun;25(3):995-6. doi: 10.1177/0962280216651022. Stat Methods Med Res. 2016. PMID: 27207088 Free article. No abstract available.
Seven useful designs.
Julious SA. Julious SA. Pharm Stat. 2012 Jan-Feb;11(1):24-31. doi: 10.1002/pst.485. Epub 2011 May 5. Pharm Stat. 2012. PMID: 21544928
Confounding and Simpson's paradox.
Julious SA, Mullee MA. Julious SA, et al. BMJ. 1994 Dec 3;309(6967):1480-1. doi: 10.1136/bmj.309.6967.1480. BMJ. 1994. PMID: 7804052 Free PMC article. No abstract available.
At-risk children with asthma (ARC): a systematic review.
Buelo A, McLean S, Julious S, Flores-Kim J, Bush A, Henderson J, Paton JY, Sheikh A, Shields M, Pinnock H; ARC Group. Buelo A, et al. Among authors: julious s. Thorax. 2018 Sep;73(9):813-824. doi: 10.1136/thoraxjnl-2017-210939. Epub 2018 Jun 5. Thorax. 2018. PMID: 29871982 Free PMC article.
158 results